# US 2021/0172014 A1 · Compositions and methods for improving sample identification in indexed nucleic acid libraries

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2021/0172014 A1
- Document ID: US20210172014A1
- Status: Published application
- Kind: A1
- Application number: 17/181,271
- Filed: 2021-02-22
- Published: 2021-06-10
- Earliest claimed: 2017-04-23
- Assignees: Illumina, Inc.; Illumina Cambridge Limited
- Applicants: Illumina, Inc.; Illumina Cambridge Limited
- Inventors: Eric Hans Vermaas; Mahdieh Khosroheidari; Claire Bevis-Mott
- Web page: https://patentgrep.com/patent/US20210172014A1

## CPC

- C12Q 1/6874: involving nucleic acid arrays, e.g. sequencing by hybridisation
- C12Q 1/6806: Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay (C12Q1/6804 takes precedence)
- C12Q 1/6809: Methods for determination or identification of nucleic acids involving differential detection
- C12Q 1/6816: characterised by the detection means (C12Q1/6804 takes precedence)
- C12Q 1/6834: Enzymatic or biochemical coupling of nucleic acids to a solid phase
- C12Q 1/6855: Ligating adaptors
- C40B 20/04: Identifying library members by means of a tag, label, or other readable or detectable entity associated with the library members, e.g. decoding processes
- C40B 50/16: involving encoding steps
- C40B 50/18: using a particular method of attachment to the solid support
- C40B 70/00: Tags or labels specially adapted for combinatorial chemistry or libraries, e.g. fluorescent tags or bar codes
- C40B 80/00: Linkers or spacers specially adapted for combinatorial chemistry or libraries, e.g. traceless linkers or safety-catch linkers
- C12Q: MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS (immunoassay G01N33/53); COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C40B: COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES (in silico combinatorial libraries of nucleic acids, proteins or peptides G16B35/00; in silico combinatorial chemistry G16C20/60)

## Abstract

The present invention is concerned with compositions and methods for improving the rate of correct sample identification in indexed nucleic acid library preparations for multiplex next generation sequencing by modifying or blocking 5′ and 3′ ends of pooled indexed polynucleotides from multiple samples, with an optional exonuclease treatment, prior to amplification and sequencing.

## Claims

### Claim at position 1

1-21. (canceled)

### Claim 22

A polynucleotide prepared for sequencing, comprising
an adapter-target-adapter sequence,
wherein the adapter sequence comprises a library specific sequence,
wherein the polynucleotide is double stranded in a region comprising the target and at least a portion of the adapter on both ends of the target, and
wherein 5′ and 3′ ends of the polynucleotide in a region of the adapter sequence are single stranded,
wherein the 5′ ends are modified to prevent digestion by an enzyme having 5′ exonuclease activity, and
wherein the 3′ ends are modified to inhibit digestion by an enzyme having 3′ exonuclease activity, to inhibit addition of nucleotides to the 3′ end by an enzyme having polymerase activity, or to inhibit digestion by an enzyme having 3′ exonuclease activity and to inhibit addition of nucleotides to the 3′ end by an enzyme having polymerase activity.

### Claim 23 (depends on 22)

The polynucleotide according to claim 22, wherein the 3′ ends are modified to inhibit digestion by an enzyme having 3′ exonuclease activity.

### Claim 24 (depends on 23)

The polynucleotide according to claim 23, wherein the 3′ ends are modified to inhibit addition of nucleotides to the 3′ end by an enzyme having polymerase activity.

### Claim 25 (depends on 22)

The polynucleotide according to claim 22, wherein the 3′ ends are modified to inhibit addition of nucleotides to the 3′ end by an enzyme having polymerase activity.

### Claim 26 (depends on 22)

The polynucleotide according to claim 22, wherein the 3′ ends comprise dideoxynucleotide.

### Claim 27 (depends on 22)

The polynucleotide according to claim 22, wherein the 5′ ends comprise a phosphorothioate bond.

### Claim 28 (depends on 22)

The polynucleotide according to claim 22, wherein the 5′ ends three phosphorothioate bonds.

### Claim 29 (depends on 22)

A method comprising:
sequencing at least a portion of the polynucleotide of claim 22.

### Claim 30 (depends on 22)

A method comprising:
hybridizing a portion of one of the single stranded regions of the adapter sequence of the polynucleotide according to claim 22 to an oligonucleotide attached to a surface, the oligonucleotide having a free 3′ end.

### Claim 31 (depends on 1, 9, 22)

The method according to claim 9, comprising extending the oligonucleotide attached to the surface of the substrate from the free 3′ end by incorporating nucleotides complementary to a sequence of the polynucleotide of claim 22 to produce a copy of the polynucleotide of claim 1 such that the copy is attached to the surface of the substrate.

### Claim 32 (depends on 31)

The method according to claim 31, comprising amplifying the copy attached to the surface of the substrate.

### Claim 33 (depends on 22)

A composition comprising the polynucleotide according to claim 22.

### Claim 34 (depends on 33)

The composition according to claim 33, comprising an exonuclease.

### Claim 35 (depends on 34)

The composition according to claim 34, wherein the exonuclease has 3′ exonuclease activity.

### Claim 36 (depends on 34)

The composition according to claim 34, wherein the exonuclease comprises Exonuclease V.

### Claim 37 (depends on 33)

The composition according to claim 33, comprising one or more enzymes having 5′ exonuclease activity and 3′ exonuclease activity.

### Claim 38 (depends on 33)

The composition according to claim 33, comprising amplification reagents.

### Claim 39 (depends on 33)

The composition according to claim 33, comprising sequencing reagents.

### Claim 40 (depends on 33)

A method comprising:
incubating an exonuclease with a composition according to claim 33.

### Claim 41 (depends on 40)

The method according to claim 40, wherein the exonuclease has 3′ exonuclease activity and 5′ exonuclease activity.
